Adicet Bio, Inc.
ACET
$9.54
-$0.19-1.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.85M | 4.08M | 6.85M | 5.10M | 3.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.30M | 21.57M | 31.89M | 27.95M | 32.39M |
| Operating Income | -22.30M | -21.57M | -31.89M | -27.95M | -32.39M |
| Income Before Tax | -21.22M | -20.24M | -30.52M | -26.86M | -31.22M |
| Income Tax Expenses | 143.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.36M | -20.24M | -30.52M | -26.86M | -31.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.36M | -20.24M | -30.52M | -26.86M | -31.22M |
| EBIT | -22.30M | -21.57M | -31.89M | -27.95M | -32.39M |
| EBITDA | -21.10M | -20.23M | -30.41M | -26.38M | -30.74M |
| EPS Basic | -1.99 | -1.88 | -2.94 | -4.72 | -5.48 |
| Normalized Basic EPS | -1.23 | -1.18 | -1.84 | -2.95 | -3.43 |
| EPS Diluted | -1.99 | -1.88 | -2.94 | -4.72 | -5.48 |
| Normalized Diluted EPS | -1.23 | -1.18 | -1.84 | -2.95 | -3.43 |
| Average Basic Shares Outstanding | 10.75M | 10.74M | 10.37M | 5.69M | 5.69M |
| Average Diluted Shares Outstanding | 10.75M | 10.74M | 10.37M | 5.69M | 5.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |